Stocks and Investing
Stocks and Investing
Tue, June 16, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, June 15, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Vikram Purohit Initiated (TBPH) at Hold and Held Target at $30 on, Jun 15th, 2020
Vikram Purohit of Morgan Stanley, Initiated "Theravance Biopharma, Inc." (TBPH) at Hold and Held Target at $30 on, Jun 15th, 2020.
Vikram has made no other calls on TBPH in the last 4 months.
There are 3 other peers that have a rating on TBPH. Out of the 3 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Vikram
- Marc Frahm of "Cowen & Co." Initiated at Buy and Held Target at $42 on, Wednesday, May 13th, 2020
- Tyler Van Buren of "Piper Sandler" Maintained at Buy with Decreased Target to $35 on, Tuesday, February 25th, 2020
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $32 on, Tuesday, February 25th, 2020